Press releases

August 8, 2012 Joining Forces with Locus Development
Genomic Health Announces Second Quarter 2012 Financial Results and Business Progress - Product Revenue Increased 13% Compared with Prior Year - - Delivered Net Income of $1.8 Million - - Began Offering Oncotype DX® Colon Cancer Test for Stage III Patients - - Combined Invitae with Locus Development to Create Independent Genetics Company - - Conference Call Today at 4:30 p.m. ET - REDWOOD CITY, Calif., Aug. 8, 2012 /PRNewswire/ – Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2012. EXCERPT FROM PRESS RELEASE REGARDING INVITAE ONLY: Update on Invitae: “As the Invitae business strategy has evolved, we recognized an increasing distinction from our core business in cancer and, at the same time, identified meaningful synergies with Locus Development, a privately held company we have been investors in since 2011. We have concluded that the best path forward is to support the combination
Read more
February 6, 2012 Company Formation
Genomic Health Announces Formation of New Genetics Subsidiary REDWOOD CITY, Calif., Feb. 6, 2012 /PRNewswire/ – Genomic Health, Inc. (Nasdaq: GHDX) today announced plans to establish a wholly owned subsidiary with the goal of improving the quality of diagnosis, communication and support for millions of patients and their families faced with common and rare genetic conditions.   The subsidiary is expected to be established by March 1, 2012 and provide its first commercial service in 2013.  The new venture will be led by Randy Scott, who in his role as Executive Chairman for the past three years has focused on commercial applications of next generation sequencing. The new subsidiary will focus on accelerating the integration of the human genome into medical practice with an emphasis on bioinformatics and clinical utility.  Dr. Scott will be CEO of the new subsidiary and remain a Genomic Health Board member and Kim Popovits,
Read more


The information in the press releases, presentations, webcasts and publications is archival and should be considered accurate only as of its date. We disclaim any obligation to supplement or update the information in these documents, presentations or webcasts.


This website contains forward-looking statements. Any statements contained in this website that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will," "intends" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including those risks and uncertainties detailed from time to time in Invitae Corporation’s periodic filings with the Securities and Exchange Commission. Invitae Corporation specifically disclaims any obligation to update any forward-looking statements.

Forward Looking Statements

Investor Toolkit

Feature Presentation

Email Alerts

Sign up to receive Invitae financial information by email.
Email Address: *

Enter the code shown above.

Investor Contact

1400 16th St.
San Francisco, CA, 94103